RYZUMVI

phentolamine mesylate · Oyster Point Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RYZUMVI, covering 2023-09-25 to 2023-11-28. Get the full timeline:

Most recent: FDA Approved: RYZUMVI — Supplemental Application (Oyster Point Pharma, Inc.)